secwatch.observer — SEC 8-K summary
======================================

Issuer:     ONCOLYTICS BIOTECH INC (ONCY)
CIK:        0001129928
Form:       8-K
Filed at:   2026-01-15T23:59:59+00:00
Accession:  0001104659-26-004103
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Oncolytics shareholders OK continuance to BC and domestication to Nevada
------------------------------------------------------------------------

- Continuance from Alberta to British Columbia approved: 85.21% in favor.
- Domestication from British Columbia to Nevada approved: 86.98% in favor.
- 2026 Incentive Award Plan approved (76.77% in favor), conditional on completion of continuance and domestication.
- Company expects to complete continuance and domestication by end of Q1 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1129928/000110465926004103/0001104659-26-004103-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1129928/000110465926004103/tm263290d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-004103

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer